Latest news
Loading news…
Repligen is a biopharmaceutical company developing consumable products for the manufacture of biological drugs.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
10
Investments
1
Monthly Visits
Available in Pro Contacts
844
Patents
187
74 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 42
- Active products
- 23
- Patents granted
- 187
- Trademarks
- 74
- Top patent class
- Physical Or Chemical Processes Or Apparatus In General
- IT spend
- $55.78M
Investor Activity
- Investments
- 1
- Lead investments
- 1
- Portfolio orgs
- 1
Company Info
- Org types
- company, investor
- HQ
- Waltham, Massachusetts, United States
Signals & Scores
- Trend (7d)
- -0.1
- Trend (30d)
- -0.4
- Trend (90d)
- -0.8
Investments by Repligen
Loading columns…
0 of 0Show
Page 1 / 1
Acquisitions by Repligen
Loading columns…
0 of 0Show
Page 1 / 1
Key People at Repligen
Director of Technology, Gene Therapy
Vice President, Product Management and Field Applications
Senior Manager, Field Applications Scientist, Upstream Bioprocess Development
Chief Financial Officer
Chief Executive Officer
Director, Global Field Applications
Chief Financial Officer
844
professional contacts at Repligen
Contact execs at Repligen →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Repligen
Loading news…
FAQs about Repligen
People who checked this page also checked these
Sectors Repligen invests & acquires in
Browse the full Acquirezy directory.